Holland-Frei Cancer Medicine

Holland-Frei Cancer Medicine
9th Ed.
2017 © John Wiley & Sons, Inc.
CARLO M. CROCE, MD; DONALD W. KUFE, MD; JAMES F. HOLLAND, MD, SCD (hc); MARTINE PICCART-GEBHART, MD, PhD; RALPH R. WEICHSELBAUM, MD; RAPHAEL E. POLLOCK, MD, PHD; ROBERT C. BAST JR, MD; WAUN KI HONG, MD, DMSc (Hon); WILLIAM N. HAIT, MD, PHD
ISBN-10: 1-118-93469-5 / ISBN-13: 978-1-118-93469-2
eISBN-10: 1-119-00083-1 / eISBN-13: 978-1-119-00083-9
Oncology

Description

The original reference resource for medical oncologists, radiation oncologists, internists, and allied specialties involved in the treatment of cancer patients, Holland-Frei Cancer Medicine covers the ever-expanding field of current cancer science and clinical oncology practice. In this new ninth edition an outstanding editorial team from world-renowned medical centers continue to hone the leading edge forged in previous editions, with timely information on biology, immunology, etiology, epidemiology, prevention, screening, pathology, imaging, and therapy.

Holland-Frei Cancer Medicine, Ninth Edition, brings scientific principles into clinical practice and is a testament to the ethos that innovative, comprehensive, multidisciplinary treatment of cancer patients must be grounded in a fundamental understanding of cancer biology.

This ninth edition features hundreds of full color illustrations, photographs, tables, graphs and algorithms that enhance understanding of complex topics and make this text an invaluable clinical tool. Over 15 brand new chapters covering the latest advances, including chapters Cancer Metabolism, Bioinformatics, Biomarker Based Clinical Trial Design, Health Services Research and Survivorship bring this comprehensive resource up-to-date. Each chapter contains overview boxes, select references and other pedagogic features, designed to make the content easy to access and absorb.

  • • A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease
  • • An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies
  • • Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics
  • • Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs

Doody's Reviews

Doody's Core Titles (DCT)
Specialty Score: 2.4 Health Sciences - Hematology/Oncology
Go to Doody's Review page

Table of Contents


Similar Resources